{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:00:44Z","timestamp":1792458044399,"version":"4.5.0"},"reference-count":55,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Ototoxicity represents a clinically significant complication of anticancer therapy in pediatric patients. Cytotoxic agents used in oncology, particularly platinum-based chemotherapy, may induce damage to the auditory and vestibular systems, resulting in hearing loss, tinnitus, and balance disturbances. Even mild hearing impairment during childhood may negatively affect speech perception, language development, communication abilities, and subsequent educational and psychosocial functioning. This narrative review aims to synthesize current evidence on treatment-related ototoxicity in children, with particular focus on commonly implicated therapies, clinical consequences, diagnostic approaches, and potential preventive strategies. A focused literature search was conducted in PubMed for publications from 2019 to 2025 addressing ototoxicity associated with pediatric anticancer treatment and audiological monitoring methods. The analysis indicates that platinum-based compounds, especially cisplatin and carboplatin, remain the primary agents associated with ototoxicity, with reported incidence ranging from approximately 20\u201370% for cisplatin and 10\u201330% for carboplatin. Additional risk factors include young age, baseline hearing status, renal function, and exposure to other ototoxic agents such as aminoglycoside antibiotics. Early detection relies on comprehensive audiological monitoring combining behavioral and objective methods, including pure-tone audiometry, extended high-frequency audiometry, otoacoustic emissions, and auditory brainstem response testing. Standardized grading systems such as ASHA, Brock, Chang, and SIOP Boston criteria play a key role in identifying and classifying ototoxic changes. Emerging research focuses on improved monitoring protocols, biomarker identification, and the development of otoprotective strategies, including sodium thiosulfate and experimental molecular therapies. Implementing systematic hearing monitoring and preventive strategies is essential to reduce long-term auditory complications and improve quality of life in pediatric cancer survivors.<\/jats:p>","DOI":"10.3390\/diagnostics16091272","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T17:04:59Z","timestamp":1776963899000},"page":"1272","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ototoxicity Associated with Antineoplastic Agents in the Pediatric Population: An Evidence-Based Review of Auditory Monitoring Strategies and Contemporary Diagnostic Frameworks\u2014Narrative Review"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9461-9204","authenticated-orcid":false,"given":"Aleksandra","family":"Wojno","sequence":"first","affiliation":[{"name":"Student Scientific Club of Otolaryngoly, Faculty of Medicine, Wroclaw Medical University, 50556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliwia","family":"Cichy","sequence":"additional","affiliation":[{"name":"Student Scientific Club of Otolaryngoly, Faculty of Medicine, Wroclaw Medical University, 50556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Wojno","sequence":"additional","affiliation":[{"name":"Student Scientific Club of Otolaryngoly, Faculty of Medicine, Wroclaw Medical University, 50556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9369-8994","authenticated-orcid":false,"given":"Karolina","family":"Dorobisz","sequence":"additional","affiliation":[{"name":"Department and Clinic of Otolaryngology, Head and Neck Surgery, Wroclaw Medical University, 50556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Pazdro-Zastawny","sequence":"additional","affiliation":[{"name":"Department and Clinic of Otolaryngology, Head and Neck Surgery, Wroclaw Medical University, 50556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bjorl.2021.02.008","article-title":"Ototoxic effects of antineoplastic drugs: A systematic review","volume":"88","author":"Patatt","year":"2022","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"ref_2","first-page":"290","article-title":"Ototoxicity in cancer survivors: Experience and proposal of a surveillance protocol","volume":"95","year":"2021","journal-title":"An. Pediatr. Engl. Ed."},{"key":"ref_3","first-page":"a1064","article-title":"Healthcare professionals\u2019 knowledge and practices in managing ototoxicity in children with cancer","volume":"71","author":"Ramnarian","year":"2024","journal-title":"S. Afr. J. Commun. Disord."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e279117","DOI":"10.1590\/1519-6984.279117","article-title":"Cisplatin and ototoxicity in childhood: The perspective of supporting otoprotective agentes","volume":"84","author":"Araujo","year":"2024","journal-title":"Braz. J. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Liu, J., Tan, J., Xiao, Q., Bai, Y., Chang, E., Su, C., Wei, Y., Zhong, H., and Wei, W. (2025). Drug-associated hearing impairment in children: A disproportionality analysis of the FDA adverse event reporting system. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1532461"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.2025-3-1","article-title":"Platinum-induced ototoxicity and hearing impairment in children and adolescents","volume":"14","author":"Romano","year":"2025","journal-title":"Drugs Context"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejpb.2021.03.008","article-title":"Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies","volume":"163","author":"Tang","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e31627","DOI":"10.1097\/MD.0000000000031627","article-title":"Platinum-induced ototoxicity in pediatric cancer survivors: GSTP1 c.313A>G variant association","volume":"101","author":"Sherief","year":"2022","journal-title":"Medicine"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Dai, D., Chen, C., Lu, C., Guo, Y., Li, Q., and Sun, C. (2024). Apoptosis, autophagy, ferroptosis, and pyroptosis in cisplatin-induced ototoxicity and protective agents. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1430469"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11764-022-01315-8","article-title":"Ototoxicity prognostic models in adult and pediatric cancer patients: A rapid review","volume":"17","author":"DeBacker","year":"2023","journal-title":"J. Cancer Surviv."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/JCMA.0000000000001023","article-title":"Otoprotection against aminoglycoside- and cisplatin-induced ototoxicity focusing on the upstream drug uptake pathway","volume":"87","author":"Hsieh","year":"2024","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_12","first-page":"a846","article-title":"Ototoxicity monitoring in South African cancer facilities: A national survey","volume":"69","author":"Ehlert","year":"2022","journal-title":"S. Afr. J. Commun. Disord."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Paken, J., Govender, C.D., Pillay, M., and Sewram, V. (2022). Cisplatin-associated ototoxicity: Perspectives from a single institution cervical cancer cohort and implications for developing a locally responsive monitoring programme in a public healthcare setting. BMC Health Serv. Res., 22.","DOI":"10.1186\/s12913-022-08099-8"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S0022215122001281","article-title":"Surveillance for ototoxicity in platinum-based chemotherapy using mobile health audiometry with extended high frequencies","volume":"137","author":"Ehlert","year":"2023","journal-title":"J. Laryngol. Otol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1044\/2021_AJA-21-00006","article-title":"Mechanisms of Aminoglycoside- and Cisplatin-Induced Ototoxicity","volume":"30","author":"Steyger","year":"2021","journal-title":"Am. J. Audiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Tan, W.J.T., and Vlajkovic, S.M. (2023). Molecular Characteristics of Cisplatin-Induced Ototoxicity and Therapeutic Interventions. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216545"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/cncr.33848","article-title":"The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments","volume":"128","author":"Meijer","year":"2022","journal-title":"Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"eaao0935","DOI":"10.1126\/scitranslmed.aao0935","article-title":"Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier","volume":"11","author":"Nyberg","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"114045","DOI":"10.1016\/j.biopha.2022.114045","article-title":"Cisplatin-induced ototoxicity: From signaling network to therapeutic targets","volume":"157","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"117174","DOI":"10.1016\/j.biopha.2024.117174","article-title":"Mangiferin alleviates cisplatin-induced ototoxicity in sensorineural hearing loss","volume":"178","author":"Lu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.3802\/jgo.2025.36.e49","article-title":"Comparison of carboplatin-based chemotherapy versus cisplatin-based chemotherapy in the treatment of malignant gonadal germ cell tumor: A systematic review and meta-analysis","volume":"36","author":"Zhang","year":"2025","journal-title":"J. Gynecol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Aiba, H., Kamei, M., Ito, Y., Takeda, R., Yamada, S., Okamoto, H., Hayashi, K., Miwa, S., Kawaguchi, Y., and Saito, S. (2023). Outcomes of Window Therapy with Carboplatin and Ifosfamide for Pediatric Osteosarcoma: A Case Series. Children, 10.","DOI":"10.3390\/children10040736"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s13193-022-01579-7","article-title":"The Incidence and Risk Factors of Cisplatin and Carboplatin Ototoxicity in Pediatric Oncology Patients at Tertiary Oncology Center","volume":"13","author":"Attar","year":"2022","journal-title":"Indian J. Surg. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/jamaoncol.2021.2224","article-title":"Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children\u2019s Oncology Group","volume":"7","author":"Leary","year":"2021","journal-title":"JAMA Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1002\/cncr.34991","article-title":"Ototoxicity associated with high-dose carboplatin for patients with previously treated germ cell tumors","volume":"129","author":"Funt","year":"2023","journal-title":"Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Rivetti, S., Romano, A., Mastrangelo, S., Attin\u00e0, G., Maurizi, P., and Ruggiero, A. (2023). Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients. Pharmaceuticals, 16.","DOI":"10.3390\/ph16101353"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/jac\/dkae106","article-title":"Pharmacogenetics of aminoglycoside-related ototoxicity: A systematic review","volume":"79","author":"Gaafar","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Fu, X., Wan, P., Li, P., Wang, J., Guo, S., Zhang, Y., An, Y., Ye, C., Liu, Z., and Gao, J. (2021). Mechanism and Prevention of Ototoxicity Induced by Aminoglycosides. Front. Cell. Neurosci., 15.","DOI":"10.3389\/fncel.2021.692762"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"732","DOI":"10.7150\/ijms.103270","article-title":"Protective effects of MET channels on aminoglycosides- and cisplatin-induced ototoxicity","volume":"22","author":"Ouyang","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Wu, P., Barros-Becker, F., Ogelman, R., Camci, E.D., Linbo, T.H., Simon, J.A., Rubel, E.W., and Raible, D.W. (2024). Multiple mechanisms of aminoglycoside ototoxicity are distinguished by subcellular localization of action. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1480435"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e002847","DOI":"10.1136\/bmjoq-2024-002847","article-title":"Improving ototoxicity monitoring in patients receiving aminoglycosides using a novel digital approach: A quality improvement project","volume":"14","author":"Cheong","year":"2025","journal-title":"BMJ Open Qual."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5604\/01.3001.0054.4669","article-title":"Ototoxicity in Immune Checkpoint Inhibitors Therapy","volume":"78","author":"Wierzbicka","year":"2024","journal-title":"Otolaryngol. Pol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1044\/2023_AJA-22-00157","article-title":"Is Methotrexate Ototoxic? Investigating the Ototoxic Late Effects of Pediatric Cancer Treatment","volume":"32","author":"Moore","year":"2023","journal-title":"Am. J. Audiol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Pasdelou, M.-P., Byelyayeva, L., Malmstr\u00f6m, S., Pucheu, S., Peytavy, M., Laullier, H., Hodges, D.B., Tzafriri, A.R., and Naert, G. (2024). Ototoxicity: A high risk to auditory function that needs to be monitored in drug development. Front. Mol. Neurosci., 17.","DOI":"10.3389\/fnmol.2024.1379743"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.7874\/jao.2025.00073","article-title":"Assessment and Management of Chemotherapy-Induced Ototoxicity in Children","volume":"29","author":"Oh","year":"2025","journal-title":"J. Audiol. Otol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40463-021-00506-0","article-title":"Insight into the current practice of ototoxicity monitoring during cisplatin therapy","volume":"50","author":"Santucci","year":"2021","journal-title":"J. Otolaryngol. Head Neck Surg."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ruggiero, A., Romano, A., Maurizi, P., Talloa, D., Fuccillo, F., Mastrangelo, S., and Attin\u00e0, G. (2025). Platinum-Induced Ototoxicity in Pediatric Cancer Patients: A Comprehensive Approach to Monitoring Strategies, Management Interventions, and Future Directions. Children, 12.","DOI":"10.3390\/children12070901"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.2147\/JMDH.S566255","article-title":"Monitoring Ototoxicity in Cancer Patients Undergoing Platinum-Based Chemotherapy and Radiation in Saudi Arabia: Challenges and Solutions","volume":"18","author":"AlJasser","year":"2025","journal-title":"J. Multidiscip. Healthc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e19052","DOI":"10.1016\/j.heliyon.2023.e19052","article-title":"The human neuroprotective placental protein composition suppressing tinnitus and restoring auditory brainstem response in a rodent model of sodium salicylate-induced ototoxicity","volume":"9","author":"Farhadi","year":"2023","journal-title":"Heliyon"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Coffin, A.B., Boney, R., Hill, J., Tian, C., and Steyger, P.S. (2021). Detecting Novel Ototoxins and Potentiation of Ototoxicity by Disease Settings. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.725566"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1044\/2023_PERSP-23-00153","article-title":"What\u2019s New in Ototoxicity Management?","volume":"9","author":"Fernandez","year":"2024","journal-title":"Perspect. ASHA Spec. Interest Groups"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/AUD.0000000000001592","article-title":"Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment","volume":"46","author":"Fernandez","year":"2025","journal-title":"Ear Hear."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/cncr.33847","article-title":"New insights into cisplatin ototoxicity","volume":"128","author":"Brock","year":"2022","journal-title":"Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1111\/odi.70046","article-title":"Ototoxicity in Cancer Therapies","volume":"31","author":"Treister","year":"2025","journal-title":"Oral Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1002\/lary.30682","article-title":"Audiologic Follow-up in Patients With Head and Neck Cancer Treated With Cisplatin and Radiation","volume":"133","author":"Lee","year":"2023","journal-title":"Laryngoscope"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"111079","DOI":"10.1016\/j.fct.2019.111079","article-title":"Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents","volume":"136","author":"Santos","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","article-title":"Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss","volume":"378","author":"Brock","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1200\/JCO.23.02353","article-title":"Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature","volume":"42","author":"Meijer","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e30550","DOI":"10.1002\/pbc.30550","article-title":"Reevaluation of sodium thiosulfate otoprotection using the consensus International Society of Paediatric Oncology Ototoxicity Scale: A report from the Children\u2019s Oncology Group study ACCL0431","volume":"70","author":"Orgel","year":"2023","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"103722","DOI":"10.1016\/j.mcn.2022.103722","article-title":"Identifying targets to prevent aminoglycoside ototoxicity","volume":"120","author":"Kim","year":"2022","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ymthe.2024.02.029","article-title":"Inhibition of Gpx4-mediated ferroptosis alleviates cisplatin-induced hearing loss in C57BL\/6 mice","volume":"32","author":"Liu","year":"2024","journal-title":"Mol. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/15548627.2022.2062872","article-title":"Increased mitophagy protects cochlear hair cells from aminoglycoside-induced damage","volume":"19","author":"Zhang","year":"2023","journal-title":"Autophagy"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2131\/jts.50.245","article-title":"An update on ototoxicity: From a genetic perspective","volume":"50","author":"Akbari","year":"2025","journal-title":"J. Toxicol. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7150\/ijbs.82003","article-title":"Inhibition of the HMGB1\/RAGE axis protects against cisplatin-induced ototoxicity via suppression of inflammation and oxidative stress","volume":"20","author":"Qiao","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"eadk9878","DOI":"10.1126\/sciadv.adk9878","article-title":"Macrophage depletion protects against cisplatin-induced ototoxicity and nephrotoxicity","volume":"10","author":"Sung","year":"2024","journal-title":"Sci. Adv."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/9\/1272\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:25:48Z","timestamp":1778142348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/9\/1272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["diagnostics16091272"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16091272","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]}}}